Fibrinogen-transmitted hepatitis; a controlled study.
D000037:Abruptio Placentae / Q000188:drug therapy; D000347:Afibrinogenemia / Q000188:drug therapy*; D001014:Aortic Aneurysm / Q000188:drug therapy; D001219:Aspartate Aminotransferases; D004619:Embolism, Amniotic Fluid / Q000188:drug therapy; D005260:Female; D005313:Fetal Death / Q000150:complications; D005340:Fibrinogen / Q000009:adverse effects*; D006470:Hemorrhage / Q000188:drug therapy*; D006509:Hepatitis B / Q000209:etiology*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D010923:Placenta Previa / Q000188:drug therapy; D011247:Pregnancy; D013903:Thoracic Surgery; D013909:Thorax / Q000601:surgery; D014597:Uterine Rupture / Q000188:drug therapy; D005719:gamma-Globulins / Q000627:therapeutic use
D005719:gamma-Globulins; D005340:Fibrinogen; D001219:Aspartate Aminotransferases